Company profile
UK company SC612928, incorporated on 6 November 2018.
Macomics | Macrophage biology. Revealed
We develop precision medicines to modulate macrophages for the treatment of cancer, by bringing together world-leading cancer biologists.
Company number SC612928
Updated 07 Jul 2026 09:49
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Macomics develops cancer therapeutics using antibody-based treatments.
As a result of our work we founded a Startup called Macomics on November 6th 2018; we are now in the process of defining a business plan and we are in a phase of advanced negotiations with an investor.
No impact. Looking for external investment.
